Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

著者: Anthony Traboulsee, Benjamin Greenberg, Jeffrey L. Bennett, L Szczechowski, Edward Fox, Svitlana Shkrobot, Takashi Yamamura, Yusuke Terada, Yuichi Kawata, Pádraig Wright, Athos Gianella-Borradori, Hideki Garren, Brian G. Weinshenker - The Lancet 2020 被引用: 490